Alternative splicing caused by lentiviral integration in the human genome

Methods in Enzymology

Volumn 507, Issue , 2012, Pages 155-169

  Moiani, Arianna ^a   Mavilio, Fulvio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Alternative splicing; Genetic diseases; HIV; Insertional mutagenesis; Posttranscriptional regulation; Retroviral vectors; Stem cells

Indexed keywords

CHIMERIC PROTEIN; LENTIVIRUS VECTOR; VIRUS VECTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; CELL CLONING; GENE CASSETTE; GENE EXPRESSION REGULATION; GENE INSERTION; GENE MAPPING; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOTOXICITY; HUMAN; HUMAN GENOME; NONHUMAN; ONCOVIRINAE; POLYADENYLATION; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION;

MURINAE;

EID: 84857614523     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386509-0.00008-9     Document Type: Chapter

References (32)

1. A. Aiuti Gene therapy for immunodeficiency due to adenosine deaminase deficiency N. Engl. J. Med. 360 2009 447 458
2. D. Almarza Risk assessment in skin gene therapy: Viral-cellular fusion transcripts generated by proviral transcriptional read-through in keratinocytes transduced with self-inactivating lentiviral vectors Gene Ther. 18 2011 674 681
3. K. Boztug Stem-cell gene therapy for the Wiskott-Aldrich syndrome N. Engl. J. Med. 363 2010 1918 1927
4. F. Bushman Genome-wide analysis of retroviral DNA integration Nat. Rev. Microbiol. 3 2005 848 858 (Pubitemid 41693180)
5. N. Cartier Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy Science 326 2009 818 823
6. C. Cattoglio Hot spots of retroviral integration in human CD34 + hematopoietic cells Blood 110 2007 1770 1778 (Pubitemid 47443887)
7. C. Cattoglio High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion PLoS One 5 2010 e15688
8. C. Cattoglio High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors Blood 116 2010 5507 5517
9. M. Cavazzana-Calvo Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia Nature 467 2010 318 322
10. J.M. Coffin Retroviruses 1997 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
11. A. Engelman, and P. Cherepanov The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication PLoS Pathog. 4 2008 e1000046
12. B. Felice Transcription factor binding sites are genetic determinants of retroviral integration in the human genome PLoS One 4 2009 e4571
13. S. Hacein-Bey-Abina Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 J. Clin. Invest. 118 2008 3132 3142
14. S. Hacein-Bey-Abina Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy N. Engl. J. Med. 346 2002 1185 1193 (Pubitemid 34984579)
15. P. Hematti Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells PLoS Biol. 2 2004 e423
16. S.J. Howe Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients J. Clin. Invest. 118 2008 3143 3150
17. M.K. Lewinski Retroviral DNA integration: Viral and cellular determinants of target-site selection PLoS Pathog. 2 2006 e60
18. G. Maruggi Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design Mol. Ther. 17 2009 851 856
19. K.A. Matreyek, and A. Engelman The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid J. Virol. 85 2011 7818 7827
20. F. Mavilio Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells Nat. Med. 12 2006 1397 1402 (Pubitemid 44924498)
21. R.S. Mitchell Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences PLoS Biol. 2 2004 E234
22. U. Modlich Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors Mol. Ther. 17 2009 1919 1928
23. E. Montini The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy J. Clin. Invest. 119 2009 964 975
24. E. Montini Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration Nat. Biotechnol. 24 2006 687 696 (Pubitemid 43882120)
25. T.W. Nilsen c-erbB activation in ALV-induced erythroblastosis: Novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor Cell 41 1985 719 726 (Pubitemid 15243379)
26. K.E. Ocwieja HIV integration targeting: A pathway involving Transportin-3 and the nuclear pore protein RanBP2 PLoS Pathog. 7 2011 e1001313
27. M.G. Ott Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 Nat. Med. 12 2006 401 409
28. A.R. Schroder HIV-1 integration in the human genome favors active genes and local hotspots Cell 110 2002 521 529 (Pubitemid 35232295)
29. S. Stein Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease Nat. Med. 16 2010 198 204
30. G.P. Wang HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications Genome Res. 17 2007 1186 1194 (Pubitemid 47204862)
31. X. Wu Transcription start regions in the human genome are favored targets for MLV integration Science 300 2003 1749 1751 (Pubitemid 36712571)
32. Q. Yang Overlapping enhancer/promoter and transcriptional termination signals in the lentiviral long terminal repeat Retrovirology 4 2007 4